Difficult Dilemmas and Cutting Edge Solutions: Advanced Topics in TB

Recordings and Training Materials:

This training was managed by the Curry International Tuberculosis Center in association with the 51st California Tuberculosis Controllers Association (CTCA) Education Conference: Health Equity and TB Elimination.

The training took place on March 8, 2017 in Walnut Creek, California.

YouTube playlist is available here: 
https://www.youtube.com/playlist?list=PLWC7cRLwcHsGf922n6MYdiMGIL02swlov

 

The training materials, including PDF handouts of the PowerPoint slides, are located here.

CME and CE units are not being offered for this recording and there is no participant evaluation.

Difficult Dilemmas and Cutting Edge Solutions: Advanced Topics in TB

1 of 5 [Horsburgh] - New TB clinical trials on the horizon

2 of 5 [Barry] - Short-course therapy for MDR-TB

3 of 5 [Shah, Alcazar] - Practical programmatic and case management issues for implementing bedaquiline

4 of 5 [Peloquin] - Therapeutic drug monitoring (TDM): practical questions and answers

5 of 5 [Jensen] - Updates in TB infection control

Difficult Dilemmas and Cutting Edge Solutions Advanced Topics in TB, 1 of 5 [Horsburgh]

Difficult Dilemmas and Cutting Edge Solutions: Advanced Topics in TB, 2 of 5 [Pennan]

Difficult Dilemmas and Cutting Edge Solutions: Advanced Topics in TB, 3 of 5 [Shah and Alcazar]

Difficult Dilemmas and Cutting Edge Solutions: Advanced Topics in TB, 4 of 5 [Peloquin]

Difficult Dilemmas and Cutting Edge Solutions: Advanced Topics in TB, 5 of 5 [Jensen]

Dates: March 8, 2017

Registration Begins: 
Friday, December 16, 2016 - 11:45am
Registration Ends: 
Friday, February 17, 2017 - 11:45pm
Training Format: 
Off-site
Location: 
The Walnut Creek Marriott
2355 North Main Street
Walnut Creek, CA 94596

This training will be conducted in association with the 51st California TB Controllers Association (CTCA) Educational Conference: Health Equity and TB Elimination, which will take place at the same venue on March 7, 2016. Separate registration is required.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Time:  9:00 am to 3:30 pm [registration: 8:15 to 9:00 am]

Application Deadline: February 3, 2017 February 17, 2017  [Notification of status in training usually takes 2-4 business days after deadline]

Enrollment is limited and pre-registration is required. To apply, please click the Apply button at the bottom of this screen. Note that you will be asked to log in if you haven't already done so. Applicants will be informed of their registration status within a few days of the application deadline. Directions and other information will be included with acceptance emails. 

Cost: There is no fee for this training. Breakfast, lunch, and coffee will be provided.

Credit: This training is approved for up to 5.25 continuing education hours (see below). Certificates will be available approximately 12 weeks after the training.

Target Audience: This training is for health care professionals who manage patients with or at risk for TB.

Training Topics:

  • New TB clinical trials on the horizon
  • Short-course treatement regimen for MDR-TB
  • Programmatic and case management issues for implementing Bedaquiline
  • Therapeutic drug monitoring: practical questions and answers
  • Updates in TB infection control 

Presenters: 

  •  Gwen Alcazar, RN, PHN, BA 
     Alameda Public Health Department

  • Pennan Barry, MD, MPH
     California Department of Public Health
  •  C. Robert Horsburgh, Jr., MD, MUS
     Boston University
  •  Paul Jensen, PHD, PE, CIH
    Centers for Disease Control and Prevention
  •  Charles Peloquin, PharmD, FCCP
    University of Florida
  •  Lisa True, RN, MS
    California Department of Public Health

.

Hotel Room Reservations: A guestroom block is available at the The Walnut Creek Marriott for $149 per night. The cutoff date for guestroom reservations is Sunday, February 19, 2017. Please reserve early.  

.

The Curry International Tuberculosis Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This training is approved for up to 5.25 continuing education hours.

The Curry International Tuberculosis Center designates this educational activity for a maximum of 5.25 AMA PRA Category 1 Credits TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The Curry International Tuberculosis Center is approved as a provider of continuing education by the California State Board of Registered Nurses, Provider Number CEP 12308. This training is approved for up to 5.25 continuing education hours. Board requirements prevent us from offering CE credit to people who arrive more than 15 minutes after the start of the training, or leave the training early. Therefore, partial credit will not be awarded.

The Curry International Tuberculosis Center is designated as a Regional Tuberculosis Training and Medical Consultation Center (RTMCC) via a funded cooperative agreement with the Centers for Disease Control and Prevention. Our RTMCC serves the western region which consists of thirteen jurisdictions: Alaska, California (including Los Angeles, San Diego, and San Francisco), Colorado, Hawaii, Idaho, Nevada, Oregon, Utah, Washington and the U.S. Pacific Island Territories. The Center welcomes inquiries from our Western Region partners regarding training, educational products, technical assistance, and medical consultation.

 

Recordings and Training Materials:

This training was managed by the Curry International Tuberculosis Center in association with the 51st California Tuberculosis Controllers Association (CTCA) Education Conference: Health Equity and TB Elimination.

The training took place on March 8, 2017 in Walnut Creek, California.

YouTube playlist is available here: 
https://www.youtube.com/playlist?list=PLWC7cRLwcHsGf922n6MYdiMGIL02swlov

 

The training materials, including PDF handouts of the PowerPoint slides, are located here.

CME and CE units are not being offered for this recording and there is no participant evaluation.

Difficult Dilemmas and Cutting Edge Solutions: Advanced Topics in TB

1 of 5 [Horsburgh] - New TB clinical trials on the horizon

2 of 5 [Barry] - Short-course therapy for MDR-TB

3 of 5 [Shah, Alcazar] - Practical programmatic and case management issues for implementing bedaquiline

4 of 5 [Peloquin] - Therapeutic drug monitoring (TDM): practical questions and answers

5 of 5 [Jensen] - Updates in TB infection control